Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip N Sambrook

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Nature Clinical Practice. Rheumatology|November 26, 2008
Consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jawPhilip N Sambrook
The New England Journal of Medicine|November 16, 2007
Anabolic therapy in glucocorticoid-induced osteoporosisPhilip N Sambrook
Current Pharmaceutical Design|August 13, 2002
Glucocorticoid osteoporosisPhilip N Sambrook
The Journal of Rheumatology. Supplement|September 6, 2005
D-hormones for prevention of bone loss after organ transplantPhilip N Sambrook
Nature Clinical Practice. Endocrinology & Metabolism|January 25, 2007
Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis?Philip N Sambrook
Therapeutic Advances in Musculoskeletal Disease|August 4, 2012
The epidemiology of osteoporosis and fractures in ankylosing spondylitisPhilip N Sambrook, Piet Geusens
Current Rheumatology Reports|May 8, 2008
Osteonecrosis of the jawPhilip N Sambrook, Peter Ebeling
The Journal of Rheumatology. Supplement|September 6, 2005
Introduction. D-hormones alfacalcidol and calcitriol for prevention and treatment of glucocorticoid/inflammation-induced osteoporosisPhilip N Sambrook, Erich Schacht
Nature Reviews. Endocrinology|September 7, 2011
Antiresorptive therapies for osteoporosis: a clinical overviewJian Sheng Chen, Philip N Sambrook
Archives of Gerontology and Geriatrics|September 20, 2011
Factors influencing adherence with therapeutic sunlight exposure in older people in intermediate care facilitiesSeeta Durvasula, Philip N Sambrook, Ian D Cameron
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Nature Clinical Practice. Rheumatology|November 26, 2008
Consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jawPhilip N Sambrook
The New England Journal of Medicine|November 16, 2007
Anabolic therapy in glucocorticoid-induced osteoporosisPhilip N Sambrook
Current Pharmaceutical Design|August 13, 2002
Glucocorticoid osteoporosisPhilip N Sambrook
The Journal of Rheumatology. Supplement|September 6, 2005
D-hormones for prevention of bone loss after organ transplantPhilip N Sambrook
Nature Clinical Practice. Endocrinology & Metabolism|January 25, 2007
Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis?Philip N Sambrook
Therapeutic Advances in Musculoskeletal Disease|August 4, 2012
The epidemiology of osteoporosis and fractures in ankylosing spondylitisPhilip N Sambrook, Piet Geusens
Current Rheumatology Reports|May 8, 2008
Osteonecrosis of the jawPhilip N Sambrook, Peter Ebeling
The Journal of Rheumatology. Supplement|September 6, 2005
Introduction. D-hormones alfacalcidol and calcitriol for prevention and treatment of glucocorticoid/inflammation-induced osteoporosisPhilip N Sambrook, Erich Schacht
Nature Reviews. Endocrinology|September 7, 2011
Antiresorptive therapies for osteoporosis: a clinical overviewJian Sheng Chen, Philip N Sambrook
Archives of Gerontology and Geriatrics|September 20, 2011
Factors influencing adherence with therapeutic sunlight exposure in older people in intermediate care facilitiesSeeta Durvasula, Philip N Sambrook, Ian D Cameron
Pageof 11